Dianthus Therapeutics's total assets for Q1 2025 were $348.58M, a decrease of -6.80% from the previous quarter. DNTH total liabilities were $19.97M for the fiscal quarter, a -7.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.